Sorrento Therapeutics (SRNEQ) Stock Chart & Stock Price History $0.0014 0.00 (0.00%) As of 07/1/2025 Add Compare Share Share Chart Stock AnalysisChartSEC FilingsBuy This Stock Sorrento Therapeutics Stock Price Performance The Sorrento Therapeutics (SRNEQ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.44%, with a year-to-date return of 180.00%. In the past month, the stock has increased 7.69%, reflecting recent market activity. As of the latest close, Sorrento Therapeutics traded at $0.00 with a market cap of $772 thousand and volume of 146,709 shares. Receive SRNEQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-36.36%1 Month Performance+7.69%3 Month Performance+40.00%Year-To-Date Performance+180.00%1 Year Performance-84.44% SRNEQ Stock Chart for Wednesday, July, 2, 2025 SRNEQ Chart by TradingView Sorrento Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$0.00$0.00-36.36%$0.00$0.00146,709 shs$772,000.0006/30/2025$0.00$0.00$0.00$0.00510,020 shs$1.21 million06/27/2025$0.00$0.00$0.00$0.00164,043 shs$1.21 million06/26/2025$0.00$0.00$0.00$0.00164,043 shs$1.21 million06/25/2025$0.00$0.00$0.00$0.00164,043 shs$1.21 million06/24/2025$0.00$0.00$0.01$0.00130,217 shs$1.21 million06/23/2025$0.00$0.00$0.01$0.00130,217 shs$1.21 million06/20/2025$0.00$0.00-16.00%$0.00$0.00378,612 shs$1.16 million06/19/2025$0.00$0.00$0.01$0.0085,199 shs$1.38 million06/18/2025$0.00$0.00$0.01$0.0085,199 shs$1.38 million Get the Latest News and Ratings for SRNEQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$0.00$0.00+19.05%$0.00$0.00115,115 shs$1.38 million06/16/2025$0.00$0.00$0.00$0.0069,045 shs$1.16 million06/13/2025$0.00$0.00$0.00$0.0022,556 shs$1.16 million06/12/2025$0.00$0.00$0.00$0.0044,014 shs$1.16 million06/11/2025$0.00$0.00$0.00$0.0049,898 shs$1.16 million06/10/2025$0.00$0.00$0.00$0.00200,505 shs$1.16 million06/09/2025$0.00$0.00$0.00$0.00122,391 shs$1.16 million06/06/2025$0.00$0.00+92.31%$0.00$0.0027,543 shs$1.38 million06/05/2025$0.00$0.00$0.00$0.0025,557 shs$717,000.0006/04/2025$0.00$0.00$0.00$0.0082,613 shs$717,000.0006/03/2025$0.00$0.00$0.00$0.007,207 shs$717,000.0006/02/2025$0.00$0.00$0.00$0.0017,913 shs$717,000.00 Related Companies MYNZ Stock Chart SNOA Stock Chart MTNB Stock Chart THAR Stock Chart GLTO Stock Chart BCTXF Stock Chart CNSP Stock Chart MBRX Stock Chart AZTR Stock Chart MBIO Stock Chart Receive SRNEQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:SRNEQ) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRNEQ Stock Alerts